IGX.F - Ingevity Corporation

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
1,668,300
1,668,300
1,391,500
1,216,100
1,292,900
Cost of Revenue
1,098,200
1,098,200
878,700
750,600
810,900
Gross Profit
570,100
570,100
512,800
465,500
482,000
Operating Expenses
Research Development
30,300
30,300
26,300
22,600
19,700
Selling General and Administrative
198,800
198,800
179,300
149,400
163,100
Total Operating Expenses
229,100
229,100
205,600
172,000
182,800
Operating Income or Loss
341,000
341,000
307,200
293,500
299,200
Interest Expense
61,800
54,300
47,700
42,200
46,900
Total Other Income/Expenses Net
-17,100
-17,100
-96,700
-16,200
-24,400
Income Before Tax
269,600
269,600
162,800
235,100
227,900
Income Tax Expense
58,000
58,000
44,700
48,900
44,200
Income from Continuing Operations
211,600
211,600
118,100
186,200
183,700
Net Income
211,600
211,600
118,100
186,200
183,700
Net Income available to common shareholders
211,600
211,600
118,100
186,200
183,700
Basic EPS
-
5.54
2.97
4.51
4.39
Diluted EPS
-
5.50
2.95
4.48
4.35
Basic Average Shares
-
38,179
39,800
41,300
41,800
Diluted Average Shares
-
38,471
40,100
41,500
42,200
EBITDA
-
432,700
320,400
377,500
384,200